Molecular imaging lab investigating biomarkers (PET & blood) for neurodegenerative diseases, focusing on early detection & therapeutic intervention in AD.
Exciting news! Our findings on the Lumipulse #pTau217 assay were featured in @theheraldsun and @dailytelegraph. In this interview, Prof. Christopher Rowe explains the difference this blood test could make for #Alzheimers diagnosis.
Have a read here: https://t.co/8GYBwMhvbs
Pleased to present our paper @eBioMedicine, on the Lumipulse plasma pTau217 assay.
Lumipulse-G platform → large global installation base in clinical pathology services → better access/uptake of plasma #ptau217 into clinical practice.
Link: https://t.co/dZaIRfJPL2
#Alzheimers
We at Rowe Lab are very proud that our PET expert, @vincentDore2 was awarded the prestigious de Leon Prize, as senior author of “CenTauR: Toward a universal scale and masks for standardizing tau imaging studies”. Time to celebrate this great achievement! #AAIC24#AIC
🌊🏄♀️ Exciting news! A postdoctoral opportunity is now available in my team in Melbourne! Join us and contribute to cutting-edge research in imaging the aging brain. #postdocopportunity#scienceAustralia 🏖️🐨🦘
https://t.co/OltJIZdnqT
#ICYMI
Professor Chris Rowe, Clinical Lead in the Florey's Dementia Mission, spoke to @7NewsMelbourne about the efficacy of a potential new blood test that can detect early signs of Alzheimer's.
In collaboration with @Austin_Health@ADNeT_Australia
& @UniMelb
Exciting results!🧠✨Our latest study showcases that plasma P217+tau can distinguish Intermediate or Advanced stage #Alzheimer's, defined based on the 2023 biological PET staging scheme. Dive into the details in our preprint:
https://t.co/ngVWhnxF90
#AlzheimersResearch
🔥 Hot off the press: our new article on VMAT2 PET as a sensitive tool to detect and quantify Parkinson’s disease (PD) progression over two years.🧠
This is a breakthrough discovery with implications for PD diagnostics and clinical trials.
#Neuroscience#Parkinsons
🔥 Hot off the press: Utilizing 18F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease
#neurology#parkinsons#biomarker#PET#NeuroTwitter https://t.co/Bw45NFzkqw
Key findings:
-Basal forebrain atrophy is associated with Aβ and cognitive impairment.
-Ch4p is more vulnerable to AD pathology than other subregions.
-The cholinergic system may be a potential target for AD early intervention
🧠 How does the basal forebrain change in normal aging and Alzheimer’s disease? 🧠
Check out our new paper that reveals the patterns of volume loss in the cholinergic system over 14 years in 516 old adults from AIBL.
#ENDALZ#Alzheimers
https://t.co/bLEfoc9knv
We’re in dire need of a standardised scale for quantification of tau PET. Drop by the poster by @vincentDore2 at site 361 to know more about the CenTauR scale.
#AAIC2023
How do blood biomarkers compare to amyloid and tau PET in predicting cognitive decline? Drop by poster 252 at #AAIC2023 to know more.
The full paper can be found here:
https://t.co/3fqdi3XKz7
Excited for Day 2 of #ADRF2023 don’t miss the presentation on prognostic utility of plasma p217+tau vs amyloid and tau PET -oral discovery session at 11.20 @AzadehFeizpour @ADRF2023
Is Service-Related Traumatic Brain Injury in #Veterans a Prelude to Alzheimer’s Disease? Read the new study now: https://t.co/JoQu1fTq1r #TBI#Alzheimers#Veterans
Amyloid PET brain imaging is a valuable diagnostic tool for detecting early signs of dementia, Alzheimer's disease and MCI. In this 2 part series, Prof Chris Rowe explains appropriate use of amyloid PET, how to read scans & accurately interpret results https://t.co/HfFUO95aMP
Privileged to have had the Victorian minister for health, infrastructure and medical research, @MaryAnneThomas visit @TheFlorey to hear about all the exciting projects, including our brain PET dementia research #dementia#Alzheimer
Melbourne is home to world's best brain research at @TheFlorey, with researchers working on treatments for Alzheimer's, the neurology of mental health, drugs for MND, & stem cells to cure Parkinson's.
Big thanks to Prof Trevor Kilpatrick & the team for welcoming me today .
Are you looking for a postdoc position in an awesome lab? Come join us! Buckley lab is seeking a postdoc (summer start, negotiable) that will work on a large multi-cohort project investigating resistance and resilience to Alzheimer's disease! https://t.co/gg14ZYHQ0M
#postdocjobs
Check out our recent paper comparing the tau PET tracers 18F-MK6240 and flortaucipir published in @jpreventionalz1, a study led by Dr Bourgeat from
@CSIRO#Alzheimer